• Find an Expert
  • Contact
  • SearchSearch icon
  • Menu
  • Help
  • Report an issue

Utilisation of Glioma Stem Cells to Investigate Novel Therapies for Glioblastoma Multiforme

Funding period: 2012 - 2013

Completed

Related publications (3)

Scholarly works icon

Molecular subtypes, stem cells and heterogeneity: Implications for personalised therapy in glioma

A Morokoff, W Ng, A Gogos, A Kaye

2015-08-01

We discuss a number of recent developments that have led to new concepts regarding the biology of gliomas. Collective tissue banki..

Scholarly works icon

Coexpression analysis of CD133 and CD44 identifies Proneural and Mesenchymal subtypes of glioblastoma multiforme

DV Brown, PM Daniel, GM D'Abaco, A Gogos, W Ng, AP Morokoff, T Mantamadiotis

2015-01-01

Accumulating evidence suggests that the stem cell markers CD133 and CD44 indicate molecular subtype in Glioblastoma Multiforme (GB..

Scholarly works icon

Complexities of lysophospholipid signalling in glioblastoma

W Ng, A Pébay, K Drummond, A Burgess, AH Kaye, A Morokoff

2014-01-01

Glioblastoma multiforme (GBM) is the most malignant brain tumour and continues to have a very poor median survival of 12-16 months..

University of Melbourne Researchers

Andrew Morokoff's Profile Picture
Andrew Morokoff

Kate Drummond's Profile Picture
Kate Drummond

Acknowledgement of Country

We acknowledge Aboriginal and Torres Strait Islander people as the Traditional Owners of the unceded lands on which we work, learn and live. We pay respect to Elders past, present and future, and acknowledge the importance of Indigenous knowledge in the Academy.

Read about our Indigenous priorities

About us  

Careers at Melbourne  

Safety and respect  

Newsroom  

Contact  

Campus locations  

Phone: 13 MELB ( 13 6352)

International: +61 3 9035 5511


Address:
The University of Melbourne
Grattan Street, Parkville,
Victoria, 3010, Australia

facebookIconlinkedinIconinstagramIcon

Emergency information  |  Disclaimer and copyright  |  Accessibility  |  Privacy

CRICOS number: 00116K     ABN: 84 002 705 224